USPSTF

Capital Digestive Care Launches AI-Driven LGI-Flag Algorithm for Predicting Lower Gastrointestinal Disorders Including Colorectal Cancer in the United States

Retrieved on: 
Tuesday, March 12, 2024
Colonoscopy, Disease, Colorectal cancer, Risk, USPSTF, Patient, CBC, Roche, FIT, Capital, Mid-Atlantic (United States), United, IBD, Inflammatory Bowel Diseases, Woman, Excellence, IBS, EHR

Available through the Roche navify Algorithm Suite, LGI-Flag is a groundbreaking AI-driven algorithm used to flag individuals at risk for lower GI disorders that warrant further evaluation.

Key Points: 
  • Available through the Roche navify Algorithm Suite, LGI-Flag is a groundbreaking AI-driven algorithm used to flag individuals at risk for lower GI disorders that warrant further evaluation.
  • "Capital Digestive Care is committed to enabling the digital transformation of healthcare, in order to provide a more personalized, convenient and predictive continuum-of-care for patients," said Michael Weinstein, M.D., CEO of Capital Digestive Care.
  • Now, we have a means to more precisely identify those at high risk of lower GI disorders, including colorectal cancer so they may avoid the devastating effects of the disease through increased screening and earlier detection and treatment."
  • "This helps advance that mission by offering a highly effective and clinically validated machine-learning-based algorithm to identify those at increased risk of a wide array of lower GI disorders, including colorectal cancer."

Olympus and the Colorectal Cancer Alliance Offer a Reminder About the Importance of Preventive Cancer Screenings

Retrieved on: 
Tuesday, March 5, 2024
Large intestine, PCP, Incidence, American Cancer Society, Woman, Texture, Gastroenterology, Colorectal cancer, Colonoscopy, TXI, Physician, Extrapyramidal system, ADR, Polyp, Colorectal Cancer Alliance, CRC, FIT, Learning, Risk, Adenoma, Health, History, USPSTF, Cancer, Patient, Diagnosis, CCA, Medical imaging

CENTER VALLEY, Pa., March 5, 2024 /PRNewswire/ -- As the American Cancer Society reports an increase in death rates from colorectal cancer for patients under the age of 50,1 Olympus Corporation of the Americas and the Colorectal Cancer Alliance (CCA) offer a reminder about the importance of preventive screenings and knowing your family health history.

Key Points: 
  • CENTER VALLEY, Pa., March 5, 2024 /PRNewswire/ -- As the American Cancer Society reports an increase in death rates from colorectal cancer for patients under the age of 50,1 Olympus Corporation of the Americas and the Colorectal Cancer Alliance (CCA) offer a reminder about the importance of preventive screenings and knowing your family health history.
  • More than 20 years ago, colorectal cancer (CRC) was known to be the fourth-leading cause of cancer death in men and women under the age of 50, according to the American Cancer Society.
  • Now, CRC is the leading cause of cancer death for men under the age of 50 and the second leading cause for women under 50.
  • Colorectal cancer is preventable, and the power to prevent it rests in your hands."

With Colorectal Cancer Rates Rising, the American Cancer Society and Colorectal Cancer Alliance Join Forces to Increase Screening

Retrieved on: 
Thursday, February 29, 2024
Large intestine, Ulcerative colitis, Incidence, American Cancer Society, Woman, Crohn's disease, Diet, Colorectal cancer, Smoking, Cancer, ACS, Hereditary nonpolyposis colorectal cancer, Weight loss, Polyp, Colorectal Cancer Alliance, Exercise, Calcium, Meat, Risk, Weakness, Survival rate, Alaska Natives, Vegetable, Rectum, USPSTF, Fatigue, Chronic pain, Death, Black, Locator, Ageing, Dairy

ATLANTA, Feb. 29, 2024 /PRNewswire/ -- The American Cancer Society (ACS) and the Colorectal Cancer Alliance (Alliance) are joining forces on Your Colon is 45 - an initiative aimed at promoting colorectal cancer screening for individuals aged 45 and above.

Key Points: 
  • ATLANTA, Feb. 29, 2024 /PRNewswire/ -- The American Cancer Society (ACS) and the Colorectal Cancer Alliance (Alliance) are joining forces on Your Colon is 45 - an initiative aimed at promoting colorectal cancer screening for individuals aged 45 and above.
  • According to the American Cancer Society's Cancer Fact & Figures, 2024 report , colorectal cancer is now the leading cause of cancer death in men and the second in women under 50 years old.
  • "By joining forces with the Colorectal Cancer Alliance, we can reach more individuals and empower them with vital information that can save lives."
  • Matching an American Cancer Society 2018 update to colorectal cancer screening guidelines , and the Alliance's call for earlier screening, the United States Preventive Services Task Force (USPSTF) released a recommendation statement lowering the age to begin colorectal cancer screening from age 50 to age 45 in 2021.

RSNA: Annual Breast Cancer Screening Beginning at 40 Saves Lives

Retrieved on: 
Tuesday, February 20, 2024
Breast cancer, Woman, Education, Physician, Radiation, RSNA, Risk, Society, Health, USPSTF, American College, National Comprehensive Cancer Network, Literature, Mortality, Research, American College of Radiology, Medical imaging

OAK BROOK, Ill., Feb. 20, 2024 /PRNewswire-PRWeb/ -- Annual breast cancer screening beginning at age 40 and continuing to at least age 79 results in the highest reduction in mortality with minimal risks, according to a new study published today in Radiology, a journal of the Radiological Society of North America (RSNA).

Key Points: 
  • Despite research demonstrating that consistent participation in screening mammography can reduce breast cancer deaths by 40%, only 50% or less of eligible women actually participate in annual screening.
  • The American College of Radiology, the Society of Breast Imaging and the National Comprehensive Cancer Network recommend annual screening for women at average risk for breast cancer beginning at age 40 and continuing as long as the woman is in good health.
  • In the study, Dr. Monticciolo and colleagues performed a secondary analysis of Cancer Intervention and Surveillance Modeling Network (CISNET) 2023 median estimates of breast cancer screening outcomes.
  • The researchers compared the benefits of screening, including mortality reduction, life years gained, breast cancer deaths averted, and its risks—including benign, or unnecessary, biopsies and recall rates—for four different scenarios: biennial screening of women 50-74 (the longstanding USPSTF recommendation), biennial screening of women 40-74 (the task force's new draft recommendation), annual screening 40-74, and annual screening 40-79.

Confusion about insurance coverage for cervical cancer screenings contributes to missed screening

Retrieved on: 
Wednesday, January 3, 2024
Testicular cancer, Affordable Care Act, PAP, Risk, Immune system, HIV/AIDS, Woman, Breast cancer, Cervical cancer, Colorectal cancer, WHO, Health, Lung cancer, HPV, Prostate cancer, Vaccination, Cancer, Skin cancer, Human papillomavirus infection, Confusion, Insurance, Letter, HIV, World Health Organization, Conditional sentence, Care Act 2014, Medicaid, Oral cancer, USPSTF, Birth control

The 2023 survey shows 41% of American women are not up to date on cervical cancer screenings.2 This indicates an urgent need to discuss the cost of cervical cancer screening, as many people may be unaware cervical cancer screenings are covered through Medicaid and most private insurance plans.

Key Points: 
  • The 2023 survey shows 41% of American women are not up to date on cervical cancer screenings.2 This indicates an urgent need to discuss the cost of cervical cancer screening, as many people may be unaware cervical cancer screenings are covered through Medicaid and most private insurance plans.
  • That means, under current law, if you have health insurance and you have a cervix, your cervical cancer screenings are covered.
  • The elimination of cervical cancer will be severely hindered without proper education across all populations about screening, insurance coverage and HPV vaccination.
  • 2The cancer screenings studied in this survey were for breast cancer, cervical cancer, colorectal cancer, oral cancer, lung cancer, prostate cancer, skin cancer and testicular cancer.

DELFI Diagnostics Supports Proposed Legislation to Allow CMS to Review New Blood-Based Screening Tests for Lung Cancer

Retrieved on: 
Wednesday, December 13, 2023
Liquid biopsy, Food and Drug Administration, Social, Woman, PALO, Food, Congress.gov, DELFI, Representative, Social Security, Mortality, Agency, XVIII, House, Death, FDA, Social Security Act, Steel, USPSTF, CMS, Lung cancer, Medicare, Congress, Louisiana House of Representatives, NCD, Prevent Cancer Foundation, Legislation, Public, Mobile phone, Dietary supplement

CMS currently lacks the authority to cover additional approaches to lung cancer screening, such as blood-based ("liquid biopsy") tests, even though access to more screening options may improve lung cancer screening rates.

Key Points: 
  • CMS currently lacks the authority to cover additional approaches to lung cancer screening, such as blood-based ("liquid biopsy") tests, even though access to more screening options may improve lung cancer screening rates.
  • If passed, this bill would enable CMS to use its national coverage determination (NCD) authority and existing coverage standards to review new lung cancer screening tests as well, expediting reviews of products that would enhance the existing lung cancer screening pathway."
  • The Lung Cancer Screening and Prevention Act would amend title XVIII of the Social Security Act to provide this authority, but does not mandate that CMS either review or cover any new lung cancer screening tests in the Medicare program.
  • The proposed legislation aligns with U.S. President Biden's Cancer Moonshot initiative focused on expanding equitable access to cancer screening and prevention, and could be a catalyst both to increasing lung cancer screening and lowering lung cancer mortality rates – key objectives of Healthy People 2030 .

Exact Sciences Awards Grants to 23 Organizations Focused on Increasing Colorectal Cancer Screenings

Retrieved on: 
Thursday, December 7, 2023
Organization, Exact Sciences (company), Colorectal cancer, CRC, Disease, Language, Collection, Patient, Data analysis, FDA, African Americans, Exact sciences, Community, United, USPSTF, FOCUS, FOCUS Program, Education, Hospital, FQHC, Colonoscopy, Health, Transport, Pharmaceutical industry, Medical device, Health insurance, Nursing, Nightclub

Grant recipients are committed to improving colorectal cancer (CRC) screening rates and making healthcare more accessible, with a focus on medically underserved populations.

Key Points: 
  • Grant recipients are committed to improving colorectal cancer (CRC) screening rates and making healthcare more accessible, with a focus on medically underserved populations.
  • Exact Sciences' FOCUS Program provides grant funding to community organizations, health foundations, public health organizations, and advocacy groups working to increase access to CRC screening.
  • Exact Sciences developed Cologuard®, the first and only FDA-approved, noninvasive, multi-target, stool-based DNA screening test that people can use at home.
  • Since making the test available in 2014, Exact Sciences has delivered more than 13 million Cologuard results to patients.

AI Identifies Non-smokers at High Risk for Lung Cancer

Retrieved on: 
Wednesday, November 22, 2023
Deep learning, Medicine, Lung, Health, RSNA, Smoker, Research, MGH, National academy, Incidence, American Cancer Society, National Comprehensive Cancer Network, Risk, Disease, Hospital, Mortality, Serum, B.A, Patient, Respiratory tract infection, Tobacco, Smoke, Artificial intelligence, Knowledge Organization (journal), Non-Smokers' Rights Association, USPSTF, Prostate, Lung cancer screening, Lung cancer, Newsroom, Harvard Medical School, Diagnosis, CIRC, Massachusetts General Hospital, Medicare, Chronic obstructive pulmonary disease, Biomarker, Cancer, Society, Radiology, Radiation, Education, Risk management, Medical imaging, Boston

The American Cancer Society estimates about 238,340 new cases of lung cancer in the United States this year and 127,070 lung cancer deaths.

Key Points: 
  • The American Cancer Society estimates about 238,340 new cases of lung cancer in the United States this year and 127,070 lung cancer deaths.
  • Existing lung cancer risk scores require information that is not readily available for most individuals, such as family history of lung cancer, pulmonary function testing or serum biomarkers.
  • For the study, CIRC researchers set out to improve lung cancer risk prediction in never-smokers by testing whether a deep learning model could identify never-smokers at high risk for lung cancer, based on their chest X-rays from the electronic medical record.
  • The high-risk group well exceeded the 1.3% six-year risk threshold where lung cancer screening CT is recommended by National Comprehensive Cancer Network guidelines.

Confusion around lung cancer screening contributes to low screening rates

Retrieved on: 
Wednesday, November 1, 2023
American Cancer Society, Cervical cancer, History, Lung cancer, Colorectal cancer, News, Prostate cancer, Testicular cancer, Risk, Confusion, Cancer, Breast cancer, DNP, CT, USPSTF, Oral cancer, Skin cancer, American Cancer Society Cancer Action Network, Prevent Cancer Foundation, Mobile phone, Medical imaging, Dairy

Alexandria, Va., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Lung cancer remains the leading cause of cancer death in the U.S. despite effective screening for those at high risk—and significant confusion about who is eligible for lung cancer screening and what screening for the disease looks like may be to blame.

Key Points: 
  • Alexandria, Va., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Lung cancer remains the leading cause of cancer death in the U.S. despite effective screening for those at high risk—and significant confusion about who is eligible for lung cancer screening and what screening for the disease looks like may be to blame.
  • This has resulted in shockingly low screening rates for a cancer that takes more than 127,000 lives in the U.S. every year.1
    The news comes from a recent report from the Prevent Cancer Foundation that found 65% of Americans 21 years of age and older say they are not up to date with one or more routine cancer screenings.2 Of all routine cancer screenings, lung cancer screening rates are the lowest— less than 6% of eligible people in the U.S. have been screened for lung cancer compared to 70% for breast cancer and 74% for colorectal cancer.
  • This spotlighted the confusion surrounding what lung cancer screening is and the lack of understanding around lung cancer screening eligibility.
  • The cancer screenings studied in this survey were for breast cancer, cervical cancer, colorectal cancer, oral cancer, lung cancer, prostate cancer, skin cancer and testicular cancer.

Predictive AI Model Identifies 55% of Commercially Insured Women Unlikely to Get a Mammogram

Retrieved on: 
Tuesday, October 24, 2023
Managed Care, General Health, Professional Services, Oncology, Consumer, Technology, Artificial Intelligence, Genetics, Health Insurance, Data Analytics, Women, Health, Benchmark, Genetic testing, Ductal carcinoma, DCIS, Health care, Snow, CDC, Risk, Breast cancer, Consultant, Susan, USPSTF, Woman, Patient, Diagnosis, Birth control, Medical imaging, Medicare

Cedar Gate Technologies (Cedar Gate) finds that of nearly 2.4 million women in its commercially insured Healthcare Benchmark Database, 55% are unlikely to get a recommended mammogram based on the company’s predictive AI model.

Key Points: 
  • Cedar Gate Technologies (Cedar Gate) finds that of nearly 2.4 million women in its commercially insured Healthcare Benchmark Database, 55% are unlikely to get a recommended mammogram based on the company’s predictive AI model.
  • These guidelines recommend that women between the ages of 40 and 75 at average risk of developing breast cancer have a screening mammogram once every two years.
  • More than 1.3 million (54.6%) of 2,388,731 women in the recommended group fell below Cedar Gate’s predictive scoring threshold.
  • These women were identified as “unlikely” to get a mammogram.